Both in Diagnostics
Immucell vs BIOMERICA
Over the past year ICCC returned +68.5% and BMRA returned −37.7%; their daily moves had a correlation of 0.03.
ICCC +68.5% BMRA −37.7%Growth of $1, one year, split-adjusted
| Metric | ICCC | BMRA |
|---|---|---|
| Price | $10.26 | $1.72 |
| Market cap | $93.2M | $7.9M |
| Today | −0.58% | −1.15% |
| 1 month | +6.9% | −23.1% |
| 6 months | +17.5% | −21.5% |
| Year to date | +66.8% | −31.7% |
| 1 year | +70.1% | −38.4% |
| Revenue growth (YoY) | +11.5% | −8.3% |
| Gross margin | 33.9% | 8.1% |
| Net margin | 25.5% | −97.4% |
| P/E (TTM) | 118.3× | — |
| Price / sales | 3.0× | 1.8× |
| Net cash | $557.3K | $2.7M |
| Dividend yield | — | — |
| Volatility (60d) | 37.4% | 72.0% |
| Short % of float | 0.3% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).